| Literature DB >> 35331255 |
Shinmi Kim1, Insook Lee2, Sun-Woo Hong3, Su-Jin Koh4.
Abstract
BACKGROUND: End-of-life care decision-making has become important to support dignity and quality of life for patients who are facing death in Korea, along with the enactment of the Life-Sustaining Treatment Act in 2018. However, it seems that the concepts and policies related to the law are not yet familiar to health care providers or the general public. This unfamiliarity can hinder efficient end-of-life care discussions. Therefore, the purpose of this study was to propose a valid and reliable tool to explore the level of understanding of concepts and attributes related to end-of-life care decisions.Entities:
Keywords: Cognitive interview; Decision-making; Psychometric tests; Terminal care
Mesh:
Year: 2022 PMID: 35331255 PMCID: PMC8944124 DOI: 10.1186/s12955-022-01952-8
Source DB: PubMed Journal: Health Qual Life Outcomes ISSN: 1477-7525 Impact factor: 3.186
Fig. 1Five steps of the study
Fig. 2The flow of conceptual attribution of the multiple standardized phases of the study. AD advance directives, CPR cardiopulmonary resuscitation, EOL-CDI end-of-life care decision inventory, EoL end-of-life, HPC hospice/palliative care, POLST-K physician’s order of life-sustaining treatment Korean, PVS persistent vegetative state
Characteristics of the participants for cognitive interviews (N = 10)
| Participants | Gender | Age | Education level | Occupation |
|---|---|---|---|---|
| Participant 1 | Male | 25 | High School | College student |
| Participant 2 | Female | 22 | High School | College student |
| Participant 3 | Female | 22 | High School | Service worker |
| Participant 4 | Male | 38 | Master’s degree | Office worker |
| Participant 5 | Female | 42 | Bachelor’s degree | Office worker |
| Participant 6 | Male | 46 | Bachelor’s degree | Businessman |
| Participant 7 | Male | 47 | Ph.D | Lecturer |
| Participant 8 | Female | 51 | Bachelor’s degree | Public officer |
| Participant 9 | Female | 66 | Middle school | None |
| Participant 10 | Female | 72 | Elementary school | None |
| Mean ± SD | 43.10 ± 17.29 |
Ph.D doctor of philosophy, SD standard deviation
General characteristics of the subjects for psychometric tests (N = 238)*
| Variables | Categories | n (%) |
|---|---|---|
| Gender | Male | 15 (6.3) |
| Female | 223 (93.7) | |
| Age(yr) | < 30 | 186 (78.2) |
| 30–39 | 35 (14.7) | |
| ≥ 40 | 17 (7.1) | |
| Spouses | No | 191 (80.6) |
| Yes | 46 (19.4) | |
| Religious | No | 153 (64.3) |
| Yes | 85 (35.7) | |
| Education | Associate degree | 19 (8.0) |
| Bachelor’s degree | 196 (82.4) | |
| Master’s degree and higher | 23 (9.7) | |
| Affiliation | General hospital | 238 (100.0) |
| Wards | Internal medicine | 47 (19.7) |
| Surgical ward | 66 (27.7) | |
| ICU | 50 (21.0) | |
| ER | 24 (10.1) | |
| Oncology | 23 (9.7) | |
| Others(OBGY, OT, UR) | 28 (11.8) | |
| Position | Staff nurse | 207 (87.0) |
| Physician assistant | 8 (3.4) | |
| Charge nurse | 13 (5.5) | |
| Unit manager | 10 (4.2) | |
Working experience (months) | < 12 | 25 (10.8) |
| 12–35 | 81 (34.9) | |
| 36–59 | 52 (22.4) | |
| 60–119 | 45 (19.4) | |
| ≥ 120 | 29 (12.5) | |
| EOL care experience | No | 78 (32.9) |
| Yes | 159 (67.1) | |
| LST Act education | No | 148 (62.2) |
| Yes | 90 (37.8) | |
| LST Act practice | No | 84 (35.4) |
| Yes | 153 (64.6) | |
| Involvement level in LST Act practice | Low | 48 (31.6) |
| Moderate | 86 (56.6) | |
| High | 18 (11.8) |
*Missing data excluded
SD standard deviation, ICU intensive care unit, ER emergent room, OBGY obstetric and gynecology, OT ophthalmology, URO urology, EOL end-of-life, LST life-sustaining treatment
Initial item analysis of EOL-CDI (29 items) (N = 238)
| Items | Mean ± SD | Item difficulty index | Discrimination index | ||
|---|---|---|---|---|---|
| CTT | IRT | CTT | IRT | ||
| EOL-CDI item 1 | 0.97 ± 0.18 | 0.97 | − 3.17 | 0.10 | 1.35 |
| EOL-CDI item 2 | 0.90 ± 0.30 | 0.90 | − 2.81 | 0.24 | 0.91 |
| EOL-CDI item 3 | 0.94 ± 0.24 | 0.94 | − 2.52 | 0.16 | 1.48 |
| EOL-CDI item 4 | 0.47 ± 0.50 | 0.48 | 0.98 | 0.18 | 0.10 |
| EOL-CDI item 5 | 0.69 ± 0.46 | 0.69 | − 2.81 | 0.26 | 0.29 |
| EOL-CDI item 6 | 0.63 ± 0.48 | 0.63 | − 3.77 | 0.23 | 0.15 |
| EOL-CDI item 7 | 0.76 ± 0.43 | 0.76 | − 4.70 | 0.25 | 0.25 |
| EOL-CDI item 8 | 0.32 ± 0.47 | 0.32 | − 6.30 | 0.06 | -0.12 |
| EOL-CDI item 9 | 0.86 ± 0.35 | 0.86 | − 2.76 | 0.23 | 0.71 |
| EOL-CDI item 10 | 0.76 ± 0.43 | 0.77 | − 2.35 | 0.26 | 0.53 |
| EOL-CDI item 11 | 0.39 ± 0.49 | 0.39 | 2.14 | 0.27 | 0.22 |
| EOL-CDI item 12 | 0.87 ± 0.33 | 0.87 | − 2.72 | 0.23 | 0.79 |
| EOL-CDI item 13 | 0.96 ± 0.20 | 0.96 | − 2.52 | 0.14 | 1.87 |
| EOL-CDI item 14 | 0.52 ± 0.50 | 0.52 | − 0.14 | 0.42 | 0.47 |
| EOL-CDI item 15 | 0.71 ± 0.45 | 0.71 | − 3.12 | 0.28 | 0.30 |
| EOL-CDI item 16 | 0.63 ± 0.48 | 0.63 | − 0.39 | 0.67 | 1.78 |
| EOL-CDI item 17 | 0.82 ± 0.39 | 0.82 | − 1.07 | 0.57 | 2.59 |
| EOL-CDI item 18 | 0.50 ± 0.50 | 0.50 | 0.06 | 0.54 | 1.04 |
| EOL-CDI item 19 | 0.11 ± 0.31 | 0.11 | 3.50 | 0.24 | 0.66 |
| EOL-CDI item 20 | 0.45 ± 0.50 | 0.45 | 0.26 | 0.66 | 1.25 |
| EOL-CDI item 21 | 0.17 ± 0.38 | 0.17 | 2.80 | 0.25 | 0.60 |
| EOL-CDI item 22 | 0.74 ± 0.44 | 0.74 | − 0.69 | 0.74 | 2.59 |
| EOL-CDI item 23 | 0.73 ± 0.45 | 0.73 | − 0.81 | 0.51 | 1.66 |
| EOL-CDI item 24 | 0.71 ± 0.45 | 0.71 | − 0.82 | 0.61 | 1.40 |
| EOL-CDI item 25 | 0.79 ± 0.41 | 0.79 | − 1.04 | 0.60 | 2.03 |
| EOL-CDI item 26 | 0.53 ± 0.50 | 0.53 | − 0.10 | 0.56 | 1.05 |
| EOL-CDI item 27 | 0.41 ± 0.49 | 0.41 | 0.47 | 0.61 | 0.97 |
| EOL-CDI item 28 | 0.29 ± 0.46 | 0.29 | 0.90 | 0.57 | 1.31 |
| EOL-CDI item 29 | 0.73 ± 0.45 | 0.73 | − 0.78 | 0.66 | 1.77 |
| Mean | 0.63 | − 1.18 | 0.38 | 1.03 | |
| SD | 2.20 | 0.73 | |||
SD standard deviation, EOL-CDI end-of-life care decision inventory, ITC item-total correlation, CTT classic test theory, IRT item response theory
Item fit statistics and point measure correlation of EOL-CDI (28 items)
| EOL-CDI item | Logit | SE | Infit | Outfit | Point measure correlation | |||
|---|---|---|---|---|---|---|---|---|
| MnSq | Z | MnSq | Z | Observed | Expected | |||
| EOL-CDI item 1 | − 3.17 | 0.40 | 0.90 | − 0.20 | 0.70 | − 0.36 | 0.42 | 0.34 |
| EOL-CDI item 2 | − 1.79 | 0.24 | 0.99 | 0.02 | 1.03 | 0.20 | 0.40 | 0.40 |
| EOL-CDI item 3 | − 2.45 | 0.30 | 0.79 | − 0.88 | 0.97 | 0.06 | 0.49 | 0.37 |
| EOL-CDI item 4 | 1.08 | 0.14 | 1.23 | 4.72 | 1.31 | 3.46 | 0.17 | 0.38 |
| EOL-CDI item 5 | − 0.01 | 0.16 | 1.22 | 2.72 | 1.30 | 2.73 | 0.24 | 0.43 |
| EOL-CDI item 6 | 0.29 | 0.15 | 1.27 | 3.82 | 1.31 | 3.27 | 0.20 | 0.42 |
| EOL-CDI item 7 | − 0.45 | 0.17 | 1.23 | 2.23 | 1.27 | 1.91 | 0.25 | 0.43 |
| EOL-CDI item 9 | − 1.24 | 0.21 | 1.05 | 0.37 | 1.15 | 0.73 | 0.37 | 0.42 |
| EOL-CDI item 10 | − 0.48 | 0.17 | 1.15 | 1.50 | 1.19 | 1.83 | 0.23 | 0.35 |
| EOL-CDI item 11 | 1.50 | 0.14 | 1.13 | 2.54 | 1.19 | 1.83 | 0.23 | 0.35 |
| EOL-CDI item 12 | − 1.42 | 0.22 | 1.10 | 0.72 | 1.08 | 0.41 | 0.34 | 0.41 |
| EOL-CDI item 13 | − 2.88 | 0.36 | 0.90 | − 0.28 | 0.59 | − 0.77 | 0.45 | 0.35 |
| EOL-CDI item 14 | 0.88 | 0.14 | 1.07 | 1.43 | 1.09 | 1.19 | 0.33 | 0.39 |
| EOL-CDI item 15 | − 0.16 | 0.16 | 1.21 | 2.40 | 1.25 | 2.14 | 0.26 | 0.43 |
| EOL-CDI item 16 | 0.32 | 0.15 | 0.84 | − 2.70 | 0.79 | − 2.63 | 0.56 | 0.42 |
| EOL-CDI item 17 | − 0.90 | 0.19 | 0.73 | − 2.52 | 0.60 | − 2.65 | 0.64 | 0.43 |
| EOL-CDI item 18 | 0.98 | 0.14 | 0.97 | − 0.73 | 0.92 | − 0.94 | 0.42 | 0.39 |
| EOL-CDI item 19 | 3.37 | 0.22 | 1.00 | 0.08 | 0.84 | − 0.49 | 0.21 | 0.20 |
| EOL-CDI item 20 | 1.20 | 0.14 | 0.90 | − 2.21 | 0.93 | − 0.82 | 0.45 | 0.37 |
| EOL-CDI item 21 | 2.75 | 0.18 | 1.00 | 0.02 | 0.97 | − 0.08 | 0.25 | 0.25 |
| EOL-CDI item 22 | − 0.31 | 0.16 | 0.72 | − 3.50 | 0.64 | − 3.27 | 0.66 | 0.43 |
| EOL-CDI item 23 | − 0.23 | 0.16 | 0.87 | − 1.59 | 0.88 | − 1.02 | 0.53 | 0.43 |
| EOL-CDI item 24 | − 0.13 | 0.16 | 0.91 | − 1.09 | 0.85 | − 1.35 | 0.50 | 0.43 |
| EOL-CDI item 25 | − 0.70 | 0.18 | 0.85 | − 1.46 | 0.66 | − 2.42 | 0.57 | 0.43 |
| EOL-CDI item 26 | 0.82 | 0.14 | 0.97 | − 0.63 | 0.98 | − 0.23 | 0.42 | 0.39 |
| EOL-CDI item 27 | 1.38 | 0.14 | 0.95 | − 1.09 | 0.93 | − 0.72 | 0.41 | 0.36 |
| EOL-CDI item 28 | 1.98 | 0.15 | 0.90 | − 1.64 | 0.80 | − 1.57 | 0.41 | 0.32 |
| EOL-CDI item 29 | − 0.23 | 0.16 | 0.84 | − 1.89 | 0.89 | − 0.95 | 0.54 | 0.43 |
| Mean ± SD | 0.99 ± 0.15 | 0.97 ± 0.22 | ||||||
EOL-CDI end-of-life care decision inventory, MnSq mean-square residual, SE standard error
MnSq of outside range > 1.3 or < 0.6, and Z-value outside range > 2.0 or < − 2.0
Standardized residuals’ variance in eigenvalue units of EOL-CDI final items (N = 238)
| Eigenvalue | Observed (%) | Expected (%) | ||
|---|---|---|---|---|
EOL-CDI (21 items) | Total raw variance in observations | 37.64 | 100.0 | 100.0 |
| Raw variance explained by measures | 16.64 | 44.2 | 43.7 | |
| Raw variance explained by persons | 7.47 | 19.8 | 19.6 | |
| Raw variance explained by items | 9.17 | 24.4 | 24.1 | |
| Raw unexplained variance (total) | 21.00 | 55.8 | 56.3 | |
| Unexplained variance in 1st contrast | 2.04 | 5.4 | 9.7 | |
| Unexplained variance in 2nd contrast | 1.70 | 4.5 | 8.1 | |
| Unexplained variance in 3rd contrast | 1.56 | 4.1 | 7.4 | |
| Unexplained variance in 4th contrast | 1.53 | 4.1 | 7.3 | |
| Unexplained variance in 5th contrast | 1.38 | 3.7 | 6.6 |
EOL-CDI end-of-life care decision inventory
Final version item fit statistics and point measure correlation of EOL-CDI (21 items) (N = 238)
| EOL-CDI item | Logit | SE | Infit | Outfit | Point measure correlation | |||
|---|---|---|---|---|---|---|---|---|
| MnSq | Z | MnSq | Z | Observed | Expected | |||
| EOL-CDI item 1 | − 3.49 | 0.41 | 0.91 | − 0.18 | 1.20 | 0.50 | 0.36 | 0.35 |
| EOL-CDI item 2 | − 2.04 | 0.25 | 1.16 | 0.94 | 1.33 | 0.91 | 0.36 | 0.46 |
| EOL-CDI item 3 | − 2.74 | 0.31 | 0.87 | − 0.55 | 1.38 | 0.80 | 0.43 | 0.40 |
| EOL-CDI item 9 | − 1.43 | 0.22 | 1.26 | 1.77 | 1.57 | 1.79 | 0.35 | 0.50 |
| EOL-CDI item 10 | − 0.57 | 0.18 | 1.34 | 2.87 | 1.45 | 2.28 | 0.33 | 0.52 |
| EOL-CDI item 12 | − 1.63 | 0.23 | 1.65 | 1.65 | 1.50 | 1.48 | 0.33 | 0.48 |
| EOL-CDI item 14 | 0.96 | 0.15 | 1.28 | 4.34 | 1.48 | 3.81 | 0.29 | 0.48 |
| EOL-CDI item 16 | 0.33 | 0.16 | 0.85 | − 2.02 | 0.78 | − 1.98 | 0.60 | 0.51 |
| EOL-CDI item 17 | − 1.04 | 0.20 | 0.70 | − 2.62 | 0.58 | − 2.09 | 0.67 | 0.51 |
| EOL-CDI item 18 | 1.08 | 0.15 | 0.99 | − 0.15 | 0.91 | − 0.81 | 0.49 | 0.48 |
| EOL-CDI item 19 | 3.63 | 0.22 | 1.01 | 0.14 | 0.96 | 0.02 | 0.24 | 0.25 |
| EOL-CDI item 20 | 1.32 | 0.15 | 0.95 | − 0.96 | 1.09 | 0.73 | 0.48 | 0.46 |
| EOL-CDI item 21 | 2.98 | 0.18 | 1.04 | 0.42 | 1.25 | 0.89 | 0.26 | 0.31 |
| EOL-CDI item 22 | − 0.38 | 0.18 | 0.73 | − 2.88 | 0.68 | − 2.18 | 0.67 | 0.52 |
| EOL-CDI item 23 | − 0.29 | 0.17 | 0.89 | − 1.19 | 0.98 | − 0.07 | 0.58 | 0.52 |
| EOL-CDI item 24 | − 0.17 | 0.17 | 0.97 | − 0.27 | 0.88 | − 0.78 | 0.55 | 0.52 |
| EOL-CDI item 25 | − 0.81 | 0.19 | 0.84 | − 1.38 | 0.66 | − 1.85 | 0.62 | 0.52 |
| EOL-CDI item 26 | 0.90 | 0.15 | 1.00 | − 0.04 | 0.97 | − 0.21 | 0.49 | 0.49 |
| EOL-CDI item 27 | 1.52 | 0.15 | 1.01 | 0.73 | 1.04 | 0.35 | 0.42 | 0.44 |
| EOL-CDI item 28 | 2.16 | 0.16 | 0.89 | − 1.63 | 0.75 | − 1.40 | 0.46 | 0.39 |
| EOL-CDI item 29 | − 0.29 | 0.17 | 0.85 | − 1.61 | 0.88 | − 0.74 | 0.60 | 0.52 |
| Mean ± SD | 0.99 ± 0.17 | 1.06 ± 0.30 | ||||||
| PCA of standardized residuals’ 1 factor eigen value = 2.04 | ||||||||
EOL-CDI, end-of-life care decision inventory; MnSq, mean-square residual; SE, standard error
MnSq of outside range > 1.3 or < 0.6, and Z-value outside range > 2.0 or < − 2.0
Fig. 3Item characteristics curve for final 21 items
Known-groups validity of EOL-CDI (N = 238)*
| Group | n | Mean ± SD | t | ||
|---|---|---|---|---|---|
| LST Act education | Yes | 90 | 14.82 ± 3.31 | 4.57 | < 0.001 |
| No | 148 | 12.58 ± 4.19 | |||
| EOL care experience | Yes | 159 | 13.83 ± 3.81 | 2.27 | 0.024 |
| No | 78 | 12.58 ± 4.35 | |||
| LST Act practice | Yes | 153 | 14.07 ± 3.58 | 3.12 | 0.002 |
| No | 84 | 12.27 ± 4.54 | |||
*Missing data excluded
EOL-CDI end-of-life care decision inventory, EoL end-of-life, LST life-sustaining treatment
Reliability of EOL-CDI (21 item)
| Separation reliability | Separation index | |
|---|---|---|
| Item | 0.99 | 8.17 |
| Person | 0.77 | 1.81 |
| Cronbach’s alpha (KR-20) | 0.81 |
EOL-CDI end-of-life care decision inventory, ACP advance care planning
| HPC is care that helps terminally ill patients die naturally and comfortably | |
| Painkillers would be stopped in HPC situation | |
| Basic medical services, such as nutrition, are provided when receiving HPC | |
| A terminally ill patient does not have the ability to make decisions | |
| A dying patient does not have the ability to make decisions | |
| LST is the treatment to treat disease | |
| CPR is performed when the heart or breathing stops | |
| AD is available to adults aged 19 or older | |
| AD is a document that specifies whether or not an adult wants LST in case he/she loses his/her ability to make a decision in advance | |
| AD can be prepared by a family member on behalf of a patient | |
| A patient may designate an agent to make a medical decision on his/her behalf using AD | |
| AD must be prepared in the designated institution | |
| In order to prepare AD, you need professional help either from a doctor or a nurse | |
| AD can be changed or abolished at any time | |
| POLST is the document completed in advance about terminally ill or dying patients’ wishes for LST at EOL | |
| POLST should be completed after the doctor explains it directly to the patient | |
| POLST cannot be changed once it is completed | |
| POLST can be completed by the opinion of the family instead of the patient | |
| POLST is a document completed by a doctor | |
| Other documents (DNR) allow to be used instead of POLST | |
| After completion of POLST, all medical services including painkillers and antibiotics will be suspended |
EOL-CDI end-of-life care decision inventory, EOL end-of-life, HPC hospice and palliative care, LST life-sustaining treatment, CPR cardiopulomary resuscitation, ACP advance care planning, AD advance directives, POLST a physician’s order of life-sustaining treatment, DNR do-not-resuscitate